ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
30
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,818
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
In-stent stenosis: pathology and implications for the development of drug eluting stents.
Author(s):
Matthew Bennett
Publication date:
2003-01-31
Journal:
Heart
Keywords:
Angiogenesis Inhibitors
,
administration & dosage
,
Brachytherapy
,
methods
,
Coronary Restenosis
,
pathology
,
prevention & control
,
Drug Implants
,
adverse effects
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Paclitaxel
,
Sirolimus
,
Stents
Read this article at
ScienceOpen
PMC
Review
Review article
Invite someone to review
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Methods by AKJournals
Author and article information
Journal
PubMed ID::
12527687
PMC ID::
1767562
ScienceOpen disciplines:
Chemistry
Keywords:
Angiogenesis Inhibitors
,
administration & dosage
,
Brachytherapy
,
methods
,
Coronary Restenosis
,
pathology
,
prevention & control
,
Drug Implants
,
adverse effects
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Paclitaxel
,
Sirolimus
,
Stents
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Angiogenesis Inhibitors
,
administration & dosage
,
Brachytherapy
,
methods
,
Coronary Restenosis
,
pathology
,
prevention & control
,
Drug Implants
,
adverse effects
,
Graft Occlusion, Vascular
,
Humans
,
Immunosuppressive Agents
,
Paclitaxel
,
Sirolimus
,
Stents
Comments
Comment on this article
Sign in to comment
Similar content
3,818
How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
Authors:
Kosmas Paraskevas
,
Frank Veith
,
J David Spence
Three-Month Outcome of Carotid Artery Stenting in Patients with/without Coexistent Unruptured Intracranial Aneurysms
Authors:
Ximeng Yang
,
Jun Lu
,
Peng Qi
…
Injectate Volumes Needed to Reach Specific Landmarks and Contrast Pattern in Kambin's Triangle Approach with Spinal Stenosis
Authors:
Ki Park
,
Ji Lee
,
Yongbum Park
See all similar
Cited by
29
Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation
Authors:
Elad Maor
,
Antoni Ivorra
,
Boris Rubinsky
MicroRNAs in cardiovascular disease
Authors:
Gerasimos Siasos
,
Evanthia Bletsa
,
Panagiota K. Stampouloglou
…
The use of nanotechnology in cardiovascular disease
Authors:
Meera Chandarana
,
Anthony D.M. Curtis
,
Clare Hoskins
See all cited by